Copyright © Inderes 2011 - present. All rights reserved.
  • Senaste
  • Börs
    • Aktiejämförelse
    • Börskalender
    • Utdelningskalender
    • Aktieanalys
    • Artiklar
  • inderesTV
  • Portfölj
  • Forum
  • Q&A
  • Om oss
    • Följda bolag
    • Teamet
Pressmeddelande

Redeye: Serstech - Stronger organisation, weaker market

Serstech

Redeye updates its estimates and valuation for Serstech following the Q2 2025 report. Quarterly financial performance came in below our estimates, although it was largely in line with what could be expected based on the announced orders. Market commentary was surprisingly soft, with intensifying price pressure, delayed procurement processes, and general market weakness. Based on this development, we have lowered our sales and gross margin estimates, while still maintaining a positive outlook for 2026e, supported by the company's expanded sales force. Our fair value range has been lowered, and we argue that new order announcements are necessary to reverse the negative share price development seen over the past six months.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments


Serstech - Stronger organisation, weaker market

Följ oss på våra kanaler i social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Ta kontakt
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • Om oss
  • Teamet
  • Jobba hos oss
  • Inderes som en investering
  • Tjänster för börsbolag
Vår plattform
  • FAQ
  • Servicevillkor
  • Integritetspolicy
  • Disclaimer
Inderes disclaimer gällande utförda aktieanalyser kan läsas här. För mer detaljerad information över de aktier som aktivt bevakas av Inderes, vänligen se respektive bolags bolagsspecifika sida på Inderes webbplats. © Inderes Oyj. Alla rättigheter förbehållna.